Regeneron is interested in obesity treatments that combat muscle loss

Regeneron is interested in obesity treatments that combat muscle loss — potentially adding trevogrumab or garetosmab to semaglutide in a bid to improve the way a patient loses weight.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks